Secondary predictors were the presence of vitreous hemorrhage (p = 0.012) in eyes that had undergone vitrectomy between 6 and 10 days after anti-VEGF injection and younger age (p = 0.031) in eyes that had undergone vitrectomy more than 10 days after anti-VEGF injection. This evidence concerns the gene VEGFA and vitreous hemorrhage.